Search results for " industry"
Article
Considerations for Optimizing Process Development
Click here to read the article >>
Intensify your cell culture processes to keep pace with today’s industry and regulatory expectations.
Article
Improving mAb Manufacturing Productivity by Optimizing Buffer and Media Prep Process Flow
BioPhorum Operations Group, “An Economic Evaluation of Buffer Preparation Philosophies for the Biopharmaceutical Industry,” BioPhorum.com, December 2019.
2. N. Deorkar, “Enhancing Cleanroom QC…
Article
Pairing Data Connectivity and Comprehensive Automation
In the biopharma industry, process data are used in many ways throughout process development and the different production phases. Learn more about Cytiva’s automation solutions for bioprocessing, ce…
Article
Production of Recombinant Adeno-associated Virus Vectors Using Microcarrier Culture of HEK293T Cells
As of March 2020, more than 4310 gene therapy clinical trials have been performed worldwide, with only 518 of them in Phase III and Phase IV. As the gene therapy projects enter clinical Phase III or g…
Article
Eliminating Residual Impurities Starts with a Strategic Plan
The availability of and reference to industry white papers might be convincing, he says. As an example, he points to the BioPhorum Operations Group (BPOG) and its guide for the assessment of leachable…
Article
The Importance of Partnering for Bioanalytical Studies
FDA, Bioanalytical Method Validation Guidance for Industry] (CDER, May 2018).
3. ICH, M10 Bioanalytical Method Validation, draft version (Feb. 26, 2019).
Article
Implementation of Process Intensification Strategies Across the Entire Cell Culture Workflow
Andreas Castan, Strategic Technology Collaborations Leader at Cytiva, will discuss the latest trends across the industry in relation to process intensification and give specific examples of how both N…
Article
The Future of Biopharma
In this article, Günter Jagschies, former Senior Director, Strategic Consumer Relations at Cytiva, highlights the evolution of the biopharma industry. Günter discuss challenges and opportunities for…
Article
Can Vaccine Development Be Safely Accelerated?
Can Vaccine Development Be Safely Accelerated?
Biopharma companies responding to the COVID-19 outbreak think accelerating the development of vaccines is safe.
By Cynthia A. Ch…
Article
Mapping a Route for Cell and Gene Therapy Process Development
While cell and gene therapies differ in many ways, some of the best practices for process development and validation are similar.
By Cynthia A. Challener
…